|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5575 | |
| A61P 27/02 |
| (11) | Number of the document | 2802331 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13700826.4 |
| Date of filing the European patent application | 2013-01-10 | |
| (97) | Date of publication of the European application | 2014-11-19 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/021023 |
| Date | 2013-01-10 |
| (87) | Number | WO 2013/106565 |
| Date | 2013-07-18 |
| (30) | Number | Date | Country code |
| 201261584877 P | 2012-01-10 | US | |
| 201261611920 P | 2012-03-16 | US |
| (72) |
AHLUWALIA, Gurpreet, US
WHITCUP, Scott M., US
BEDDINGFIELD, Frederick C., US
EDWARDS, Sydney G., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | TOPICAL TREATMENT FOR CHEMOTHERAPY INDUCED EYELASH LOSS OR HYPOTRICHOSIS USING PROSTAMIDE F2 ALPHA AGONISTS |
| TOPICAL TREATMENT FOR CHEMOTHERAPY INDUCED EYELASH LOSS OR HYPOTRICHOSIS USING PROSTAMIDE F2 ALPHA AGONISTS |